
IO Biotech is a clinical-stage biopharmaceutical company pioneering the first dual-action immune-modulating cancer vaccine with the goal of becoming the backbone of combination therapy for people with cancer.
IO Biotech CEO
Eslam Hussein is CEO of IO Biotech.
IO Biotech FAQ
Is IO Biotech publicly traded?
Yes. IO Biotech is a public company.
Who is the CEO of IO Biotech?
Eslam Hussein is the CEO of IO Biotech.
Categories
How this page is sourced
Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Sep 2, 2026Data disclaimerReport a correctionClaim this profileRun IO Biotech? Join the podcast